Nuwellis (NUWE) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nexalin Technology is the larger company by market cap ($3.4 million vs $2.5 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUWE | NXL |
|---|---|---|
| Share price | $0.6751 | $4.11 |
| Market cap | $2.46M | $3.41M |
| 1-day change | -1.92% | -4.86% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $435.92 | $-14.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $172.90 | $50.70 |
| 52-week low | $0.67 | $3.97 |
| Distance from 52-week high | -99.61% | -91.89% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +264.96% |
| Average volume | 4.33M | 1.02M |
| Shares outstanding | 3.65M | 829.40K |
| Employees | 38 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Nuwellis
NUWE stock →Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
NUWE vs NXL FAQ
Which is bigger, Nuwellis or Nexalin Technology?
Nexalin Technology (NXL) is larger, with a market capitalization of $3.41M compared with $2.46M for Nuwellis (NUWE).
Are Nuwellis and Nexalin Technology in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.